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Background: Previous research has shown that in Chronic Obstructive Pulmonary Disease (COPD) patients, it is
important to consider not only physical functioning and complaints but also psychological factors, such as illness
perceptions, to explain differences in Health-Related Quality of Life (HRQoL). The objective of this study is to analyse
the extent to which the specific dimensions of illness perceptions according to the Common Sense Model
(corrected for airflow limitation, dyspnoea and comorbidities) contribute to HRQoL.
Method: In a cross-sectional study in primary care, 90 COPD patients completed questionnaires: The Brief Illness
Perception Questionnaire, the Medical Research Council dyspnoea scale, the Clinical COPD Questionnaire (CCQ) and
the Chronic Respiratory Questionnaire (CRQ). Analyses were performed with multiple linear regression.
Results: When corrected for confounders (airflow limitation, dyspnoea and comorbidities), identity (β = .42) and
comprehensibility (β = −.16) were associated with HRQoL (CCQ). Identity, comprehensibility and dyspnoea explained
56% of the variation in HRQoL (R2 = .56). Consequences (β = −.50) and treatment control (β = .20) were associated
with HRQoL (the CRQ’s physical domain). They explained 59% of the variation in the CRQ physical (R2 = .59) domain.
Treatment control (β = .19) and emotional response (β = −.33) were associated with the CRQ emotional domain.
Conclusions: Patients who experience fewer symptoms attributed to COPD, who have a better understanding of
the disease, who experience less impact of COPD in daily life, who experience better treatment control and who
have less of an emotional response have better HRQoL. This study indicates that the HRQoL of COPD patients is
associated with illness perceptions as well as with the severity of dyspnoea as experienced by patients. Airflow
limitation measures or comorbidities do not add to the explanation of HRQoL. The results of this study provide
starting points for the development of interventions focusing on illness perceptions to support COPD patients in
their disease management and to improve HRQoL.
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Chronic Obstructive Pulmonary Disease (COPD) is a
chronic disease characterised by progressive and persist-
ent airflow limitation [1]. In the Netherlands, more than
360,000 people have been diagnosed with COPD [2].
The prevalence is estimated at 2.3% of men and 2.1% of
women [2]. COPD patients may face limitations in daily
activities and reduced quality of life caused by dyspnoea,
airflow limitation, skeletal muscle dysfunction, and comor-
bidities [1,3]. Three major goals of COPD care and treat-
ment are to reduce symptoms, increase participation in
daily activities and improve health-related quality of life
(HRQoL) [1]. In primary care settings in the Netherlands
and many other countries, care for patients with COPD
has increasingly moved from hospitals to primary care set-
tings. Practice nurses have become essential in supporting
COPD patients in their disease management [4].
The pulmonary and extrapulmonary effects of the dis-
ease have an impact on physical, emotional, and mental
well-being in COPD patients [5,6]. Although the assess-
ment of COPD relies mainly on the degree of airflow
limitation (i.e., the decrease in forced expiratory volume
in one second (FEV1)), there is evidence that FEV1 has
a relatively poor correlation with symptoms, HRQoL
and daily functioning [7-9]. Therefore, other models in
addition to strict medical models are increasingly used
to explain differences in daily functioning and HRQoL
in chronically ill patients. These models presume that
biological factors as well as psychological and social fac-
tors play a significant role in the explanation of function-
ing and HRQoL in chronic illnesses [10,11]. One of the
psychological factors that is considered important in this
context is illness perceptions. Illness perceptions are the
central concept of the Common Sense Model (CSM)
[12,13]. This model suggests that people have personal
beliefs about their illness that often do not match med-
ical views but that nevertheless determine, to a large ex-
tent, how people respond to their illness. These illness
perceptions include beliefs about consequences, the
timeline of the disease, ability to control the disease and
the extent to which the treatment helps in controlling
the disease. They also include perceptions of symptoms
attributed to the disease (identity), understanding of the
disease, concerns and emotional response to the disease
[12-14]. The CSM presumes that these various dimen-
sions of illness perceptions are logically related to health
behaviours and HRQoL. Therefore, these perceptions
are considered key elements for understanding the ways
that people attempt to manage threats to their health
[12,13]. The CSM is depicted in Figure 1.
Previous research in outpatient and clinical popula-
tions has demonstrated that COPD patients who believe
that the impact of the disease on daily life is less serious,
who have positive beliefs about the treatment and whohave less strong emotional reactions have better HRQoL
than patients who have more negative beliefs [16-18]. Our
previous study of COPD patients in a primary care setting,
which explored the extent to which the combination of ill-
ness perceptions, proactive coping and depressive symp-
toms contribute to daily activities and HRQoL, revealed
that illness perceptions are associated with HRQoL. More
positive perceptions of illness were related to better
HRQoL [9]. In this study, we will expand on our earlier re-
search by analysing the extent to which the specific di-
mensions of illness perceptions contribute to HRQoL.
Investigating these dimensions of illness perceptions in
patients with mild to severe COPD allows us to test the
assumption of the CS Model that specific beliefs about
consequences, the timeline of the disease, ability to con-
trol the disease, ability to control the disease by treatment,
symptoms, comprehensibility of the disease, emotional re-
sponse and concerns are related to HRQoL.
Method
Study design and participants
This cross-sectional study was conducted in ten general
practices throughout the Netherlands between June 2010
and April 2011. The study sample consisted of COPD pa-
tients who attended the participating general practices
and visited the practice nurses during consulting- hours.
The patients included in the study complied with the
following criteria: a diagnosis of mild COPD (GOLD I),
moderate COPD (GOLD II) or severe COPD (GOLD III)
[1]. The GOLD (Global initiative for chronic Obstructive
Lung Disease) is a classification of severity of airflow limita-
tion in COPD based on post-bronchodilator forced expira-
tory volume in one second (FEV1) and the forced vital
capacity (FVC) [1]. Furthermore, they had to be both phys-
ically and mentally able to complete the questionnaires. Pa-
tients were excluded if they had participated in another
study or if they had a primary diagnosis of asthma. The
Medical Research Ethics Committee (MREC) of the Uni-
versity Hospital Utrecht concluded that the Medical Re-
search Involving Human Subjects Act (WMO) does not
apply to this study; therefore, no WMO approval by the
MREC was needed. The MREC ensured that the individ-
uals involved in the study were adequately informed that
their data would be used for research proposes. All partici-
pants provided written informed consent to participate in
the study.
Procedure
Eleven practice nurses working in ten participating gen-
eral practices asked eligible COPD patients who visited
them during consulting-hours if they would be willing to
participate in the study. Eligible patients who expressed
willingness to participate received a standardised letter
explaining the aims of the study, particularly that the
Figure 1 The Common sense model (Adapted from Hagger et al. and Kaptein et al.) [13,15].
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After giving written informed consent, the participating
patients completed the questionnaires at home and then




To assess the various dimensions of illness perceptions,
the Brief Illness Perception Questionnaire (B-IPQ) [19]
was used. This brief version was used because it is more
suitable, less taxing, much quicker and much easier to
complete than the long version IPQ-R [20]. The B-IPQ
is a self-administered scale consisting of eight items on
an 11-point scale (range 0–10). Each item represents a
dimension of the CSM (Figure 1). Five items assess cog-
nitive representations of the illness, and three items as-
sess the emotional representation of the illness. The
dimensions and implications of the scores are depicted
in Table 1. A higher score on these dimensions implies
that patients believed in a stronger influence of illness
upon daily life (“consequences”), held stronger belief in a
chronic time course (“timeline”), had greater perceived
personal control of illness (“personal control”), had
greater perceived control of the disease by treatment
(“treatment control”), and had a greater experience of se-
vere symptoms as a result of the illness (“identity”). Two
of the items assess emotional representations of illness.
A higher score implies that patients had greater feelings
of concern about the illness (“concern”) and a strongeremotional response to the illness (“emotional response”).
One questionnaire item assesses “comprehensibility”; a
higher score implies a better understanding of the ill-
ness. One open-ended item assesses causal beliefs about
COPD. This item asks patients to list their views on the
three most important causal factors of their illness.
Dyspnoea
The MRC dyspnoea scale is a questionnaire that consists
of six statements about perceived breathlessness: grade
0, “I don’t suffer from shortness of breath” grade 1, “I
only get breathless with strenuous exercise”; grade 2, “I
get short of breath when hurrying on the level or up a
slight hill”; grade 3, “I walk slower than people of the
same age on the level because of breathlessness or have
to stop for breath when walking at my own pace on the
level”; grade 4, “I stop for breath after walking 100 yards
or after a few minutes on the level”; and grade 5, “ I am
too breathless to leave the house” [21]. Patients selected
the grade that applied to them.
Health-related quality of life
To measure HRQoL, the Clinical COPD Questionnaire
(CCQ) [22] and the Chronic Respiratory Disease Ques-
tionnaire Self-Administered Short version (CRQ-SAS)
[23] were used. The CCQ is a self-administered ques-
tionnaire consisting of 10 questions. Response options
range from 0 (“no limitations/asymptomatic”) to 6 (“to-
tally limited/extremely symptomatic”). The total score
is computed by summing the scores and dividing the
Table 1 The dimensions of the Brief-Illness Perception
Questionnaire (B-IPQ) [19]
Dimensions B-IPQ Higher score implies:
Consequences Greater perceived influences of COPD
Timeline A stronger belief in a chronic time course
Personal control Greater perceived personal control
Treatment control Greater perceived control by treatment
Identity Greater experience of severe symptoms as a result
of COPD
Concern Greater feelings of concern about COPD
Comprehensibility A better understanding of the illness
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cate lower HRQoL.
The CRQ-SAS is a 20-item self-administered question-
naire covering four dimensions: dyspnoea, fatigue, emo-
tional function and mastery. The response options for
each question range from 1 (maximum impairment) to 7
(no impairment). The total score per domain is com-
puted by summing the scores and dividing the total
score by the number of items. In the analyses, the CRQ-
SAS was divided into two domains: the CRQ-SAS phys-
ical domain (the mean of the dyspnoea and fatigue do-
mains) and the CRQ-SAS emotional domain (the mean
of the emotional function and mastery domains). Higher
scores indicate better HRQoL.
In addition, data on pulmonary function were collected:
FEV1 in litres and FVC in litres. To calculate the predicted
forced expiratory volume percentage (FEV1% predicted),
data on height and weight (according to the local general
practitioner registry) were collected. Co-morbidities were
measured by the Charlson comorbidity index [24]. This
index is a validated method of classifying comorbidity
from medical records and measures 17 conditions. The
index score is the total of assigned weights and repre-
sents a measure of the burden of comorbidity [24,25].
Sociodemographic variables, such as age, gender, edu-
cation level (based on the International Standard Classi-
fication of Education: ISCED) [26], working status,
marital status and disease-related variables (medication
use, smoking status) were also collected.Analyses
Descriptive statistics were used to present patients’ back-
grounds, medical characteristics and their causal beliefs
about COPD.
Linear regression analyses (adjusted for the confounders
age, gender, dyspnoea, airflow reduction and comorbidi-
ties) were performed to quantify the associations between
illness perceptions and HRQoL [27].
First, a crude model with the eight specific dimensions
of illness perceptions (model 1) was analysed. In thesecond model (model 2), illness perceptions were cor-
rected for the confounders of age and gender. In the
third model (model 3), illness perceptions were adjusted
for dyspnoea, airflow reduction (FEV1%predicted) and
comorbidities. In the regression models, the standardised
βs were used to compare the strength of the various in-
dependent variables. The adjusted explained variance
(adjusted R2) per model was then analysed. Because only
3% of the data was missing, a complete case analysis was
performed. All analyses were performed with the Statis-




A total of 98 patients completed the questionnaires. In
the analyses, it was found that eight patients had no
COPD; they had a GOLD stage of 0 with an FEV1/FVC
ratio >70%. Therefore, these patients were excluded
from the analyses. The sample characteristics of the 90 pa-
tients are presented in Table 2. The mean age of the pa-
tients in the study sample was 65, with a standard
deviation (SD) of 9.0. Forty-six percent of study sample
was women. Most patients (n = 60, 67%) had moderate
COPD (GOLD grade II). Half of the patients were retired
(51%). In the non-retired population (n = 44), 20 patients
(22% from the total population) had full-time jobs. Most
of the patients had a medium educational level (62%).
Illness perceptions and disease-related characteristics
The means, standard deviations, range of various dimen-
sions of illness perceptions, dyspnoea, airflow limitations
(FEV1), and HRQoL are presented in Table 3. In general,
given their mean scores on the dimensions of illness per-
ceptions, participants in this study considered their
COPD chronic but not very serious, easily controlled by
medical care or self-care, and with only minor conse-
quences for daily life (Table 3). Most patients believe
that smoking caused their COPD (71%), followed by her-
edity (22%), air pollution (16%) and allergy (8%).
Illness perceptions and HRQoL
As shown in the crude regression model, which is not
corrected for confounders (model 1, Table 4), consequences
(β = .26), identity (β = .43) and comprehensibility (β = −.16)
were associated with HRQoL as measured by the CCQ.
When corrected for the confounders of age and gender
(model 2), only identity (β = .44) was associated with
HRQoL. In model 3, corrected for the confounders of
dyspnoea, FEV1%predicted and comorbidities, identity
(β = .42) and comprehensibility (β = −.16) were associated
with HRQoL. Identity, comprehensibility and dyspnoea
explained 56% of the variation in HRQoL in model 3
(R2 = .56). FEV%pred and comorbidity were not
Table 2 Patient characteristics





Mean 65.19 (SD 9.0)




> 80 5 (5.6%)
Years diagnosed with COPD
Mean disease severity
8.1 (SD 8.11)
GOLDa I 18 (20.0%)
GOLD II 60 (66.7%)
GOLD III 12 (13.3%)
FEV1 mean 1.9 (1.0-3.7) (SD .59)













Current smoker 36 (40.0%)
Former smoker 49 (54.4%)
Never smoked 5 (5.6%)
Medication use 82 (91.1%)
Charlson comorbidity index, ≥1 28 (31.1%)
aGlobal Initiative for Chronic Obstructive Lung Disease.
bCategories are based on the International Standard Classification of Education
(ISCED) [26].
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COPD patients with weaker perceptions of identity and
greater understanding (comprehensibility) of the disease
have better HRQoL.
As shown in Table 5 (model 1 and model 2), conse-
quences (β = −.55) and treatment control (β = .16) were
associated with HRQoL as measured by the CRQ-SAS
physical domain. When corrected for the confounders of
dyspnoea, FEV1%predicted and comorbidity (Table 5,model 3), consequences (β = −.50) and treatment control
(β = .20) were associated with the CRQ-SAS’s physical
domain. Consequences, treatment control and dyspnoea
explained 59% of the variation in the CRQ-SAS’s phys-
ical domain (R2 = .59). These results indicate that COPD
patients with weaker perceived consequences and more
perceived effectiveness of the treatment have better
HRQoL as measured by the CRQ-SAS’s physical domain
(the mean of the dyspnoea and fatigue domains).
As shown in Table 6 (model 1, 2 and 3), treatment
control (β = .19) and emotional response (β = −.33 - –.40)
were associated with the CRQ-SAS’s emotional domain.
Treatment control, emotional response and dyspnoea ex-
plained 35% of the variation in the CRQ-SAS’s emotional
domain. These results indicate that COPD patients with
better treatment control and a weaker emotional re-
sponse to their disease have better HRQoL as measured
by the CRQ-SAS’s emotional domain (the mean of the
emotional function and mastery domains).
Discussion
This study shows that specific dimensions of illness per-
ceptions are associated with HRQoL in COPD patients
with mild to severe COPD (GOLD I-III) who receive
medical support from a primary care physician and a
practice nurse in primary care. COPD patients have bet-
ter HRQoL when they experience fewer symptoms at-
tributed to COPD (identity), experience less impact in
daily life (consequences), experience fewer emotional
consequences (emotional response), have stronger beliefs
about control of their treatment and have a greater un-
derstanding of the disease (comprehensibility). When
corrected for dyspnoea, airflow limitation and co-
morbidity, identity, comprehensibility and dyspnoea
explained 56% of the variation in HRQoL (CCQ). Con-
sequences, treatment control and dyspnoea explained
59% of the variation in HRQoL (the CRQ-SAS’s phys-
ical domain), and emotional response and dyspnoea ex-
plained 35% of the variance in HRQoL (the CRQ-SAS’s
emotional domain).
The findings of our study are in line with the results
of other studies regarding illness perceptions in COPD
patients. Scharloo [28] and colleagues have concluded
that outpatient COPD patients who have a strong illness
identity and strong beliefs regarding the consequences of
their illness have worse general functioning and HRQoL.
In another study by Scharloo [16] of outpatient COPD
patients, decreased symptoms, more positive beliefs
about the effects and outcomes of treatment and less
strong emotional reactions were associated with higher
HRQoL. Our data support these findings. Our findings
are also in line with findings regarding illness percep-
tions in COPD patients undergoing rehabilitation;
more positive and adaptive attitudes about treatment
Table 3 Descriptions of illness perceptions (B-IPQ), MRC dyspnoea, FEV1 and Health-Related Quality of Life (CCQ and
CRQ) (N = 88–90)
Mean (SD) Range Ref range Percentage
Illness perceptions (B-IPQ)
Consequences 3.6 (2.5) 0-9 0–10
Timeline 9.1 (2.1) 0-10 0–10
Personal control 6.0 (2.5) 0-10 0–10
Treatment control 6.8 (2.7) 0-10 0–10
Identity 4.0 (2.6) 0-10 0–10
Concern 4.1 (3.1) 0-10 0–10
Comprehensibility 7.6 (2.7) 0-10 0–10







MRC dyspnoea 1.7 (1.0) 0-5 0-6
FEV1 (litres) 1.9 (0.6) 1.0-3.7
FEV% pred 67.0 (14.4) 36.5-101.2
HRQoL: CCQ 1.4 (0.8) 0.0-3.8 0-6
HRQoL: CRQ:
CRQ-SAS physical 5.6 (1.3) 2.70-7.00 1-7
CRQ-SAS emotional 5.60 (1.0) 2.73-7.00 1-7
B-IPQ = Brief Illness Perception Questionnaire, CCQ- = Clinical COPD Questionnaire, CRQ-SAS = Chronic Respiratory Disease Questionnaire Self-Administered Short
version, CRQ-SAS physical = CRQ-SAS dyspnoea domain and CRQ-SAS fatigue domain, CRQ-SAS emotional = CRQ-SAS emotional domain and CRQ-SAS mastery
domain, FEV1 = Forced Expiratory Volume in 1 second, FEV%pred = Forced Expiratory Volume Percentage from predicted, HRQoL = Health-Related Quality of Life,
MRC dyspnoea =Medical Research Council dyspnoea scale.
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[17,29,30].
Although some studies show that coping with illness
mediates the relationship between illness perceptions
and the overall outcome of the illness [13], our previous
research [9] and research by Heijmans et al. [31,32] has
revealed that HRQoL is more influenced by illness per-
ceptions than by coping strategies.
Our study lends support to the Common Sense Model
(CSM), [12] which suggests that people hold views and
beliefs about their illness that are associated with their
HRQoL. These illness perceptions are the key elements
for understanding how people manage threats to their
health and experience their HRQoL [12].
To appreciate the findings of this study, some aspects
require further consideration. The current study has
some limitations. First, because of the cross-sectional
nature of this study, the associations between the dimen-
sions of illness perceptions and HRQoL should not be
understood as implying a causal relationship. In light of
these findings, it is important to address the possibilityof some conceptual overlap between the specific dimen-
sions of illness perceptions and HRQoL. There were
some significant correlations between the illness percep-
tion dimensions and the HRQoL measures, but they
were too low to determine collinearity. Longitudinal data
will enable us to explain the relationship between illness
perceptions and HRQoL in more detail. Second, the βs
in the regression models were small, indicating small
clinical changes per unit change. Third, the sample size
did not allow for subgroup analyses per GOLD grade.
Therefore, we could not describe the associations in the
different stages of COPD. Furthermore all measures
were questionnaires. It could be questioned whether a
questionnaire is the best measure of illness perceptions
because the development of perceptions is partially an
unconscious process. Qualitative interviews might be
preferable to questionnaires. However, the aim of the
study was to quantify the relationship between illness
perceptions and HRQoL, for which regression analysis
is the preferred method. Furthermore, patient-reported
outcome measures of illness perceptions (B-IPQ)
Table 5 Regression models between various illness perceptions items and dependent variable health-related quality of
life (CRQ physical) N = 87
Model 1 (Block 1) Model 2 (Block 1 and 2) Model 3 (Block 1 and 3)
R2 β R2 β R2 β
Block 1:Perceptions .49 .49 .59
Consequences –.55*** –.55*** –.50***
Timeline –.16 –.14 –.08
Personal control –.09 –.08 –.06
Treatment control .16* .16* .20**
Identity –.09 .11 –.06
Illness concern .01 .02 .06
Comprehensibility .07 .04 . 07
Emotional response –.15 –.14 -.17
Block 2: Demographic characteristics
Age –.01
Gender –.10




F change 11.25*** 7.69 6.47***
R2 is an adjusted R2. β is a standardised β.
*P ≤ 0.05; **P ≤ 0.01; ***p < 0.001.
FEV%pred = forced expiratory volume percentage from predicted, MRC dyspnoea =Medical Research Council dyspnoea scale.
Table 4 Regression models between various illness perception items and dependent variable health-related quality of
life (CCQ) N = 86
Model 1 (Block 1) Model 2 (Block 1 and 2) Model 3 (Block 1 and 3)
R2 β R2 β R2 β
Block 1: Perceptions .53 .54 .56
Consequences .26* .26 .21
Timeline .01 –.01 –.03
Personal control .03 .02 .04
Treatment control –.11 –.16 –.15
Identity .43** .44** .42**
Illness concern .02 .03 –.01
Comprehensibility –.16* –.13 –.16*
Emotional response .16 .09 .13
Block 2: Demographic characteristics
Age .06
Gender .10




F change model 13.9*** 1.00 2.3***
R2 is an adjusted R2. β is a standardised β.
*P ≤ 0.05; ** P ≤ 0.01; *** p < 0.001.
FEV%pred = forced expiratory volume percentage from predicted, MRC dyspnoea =Medical Research Council dyspnoea scale.
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Table 6 Regression models between separate illness perception items and dependent variable health-related quality of
life (CRQ emotional) N = 87
Model 1 (Block 1) Model 2 (Block 1 and 2) Model 3 (Block 1 and 3)
R2 β R2 β R2 β
Block 1:Perceptions .32 .32 .35
Consequences –.17 -.17 –.14
Timeline .01 .03 .05
Personal control .03 .05 .05
Treatment control .17 .17 .19*
Identity –.08 -.10
Illness concern –.03 -.01
Comprehensibility –.53 -.09
Emotional response –.40** –.39** –.33*
Block 2: Demographic characteristics
Age –.02
Gender –.14




F change model 6.01*** 1.08 1.74
R2 is an adjusted R2. β is a standardised β.
* P ≤ 0.05; ** P ≤ 0.01; *** p < 0.001.
FEV%pred = forced expiratory volume percentage from predicted, MRC dyspnoea =Medical Research Council dyspnoea scale.
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and reliable.
The strength of the present study is its generalisability.
In our study population, 20% of the patients had mild
COPD (GOLD grade I), and almost 70% of the patients
had moderate COPD (GOLD grade II). This sample is in
line with the distribution of COPD patients in primary
care [4]. Moreover, we did not exclude patients with co-
morbidities. Therefore, our study population is represen-
tative of the primary care population.
Conclusions
This study highlights the importance of patients’ beliefs
about their illness and symptoms in relation to HRQoL.
The results of this study indicate that the HRQoL of
COPD patients is associated with illness perceptions to-
gether with the severity of dyspnoea as experienced by
patients. More objective measures, such as airflow limi-
tation measures or comorbidities, do not add to the ex-
planation of HRQoL.
A major goal of COPD treatment is to improve HRQoL
[1], and this study contributes to the existing knowledge
concerning the associations between illness perceptions
and HRQoL. Despite their importance, patients’ beliefs
and views of their symptoms and illness are rarely dis-
cussed in consultations [14]. The results of this study con-
firm the existing knowledge and provide starting pointsfor the development of interventions focusing on illness
perceptions both to support COPD patients in their dis-
ease management and to improve HRQoL. Because evi-
dence suggests that the degree of physician-patient
concordance regarding perceptions of symptoms is poor
[35,36] and that addressing illness perceptions is more
important than interpersonal skills in relation to patient
adherence [37], the starting point should be to explore
these illness perceptions (e.g., with questionnaires) [38].
The second step should be to discuss these perceptions
and, if necessary, to correct them at an early stage. Real-
istic positive beliefs should be encouraged, and negative
beliefs should be prevented or challenged [18,39,40].
This approach may result in better HRQoL in COPD
patients. Because interventions focusing on illness per-
ceptions have only recently been described in patients
with other chronic diseases [41-43], it is important to
develop and test an illness perception intervention for
COPD patients in primary care settings.
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